Refractory and Relapsing Multiple Myeloma Treated by Blood Stem Cell Transplantation
- 1 March 1995
- journal article
- research article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 309 (3), 152-161
- https://doi.org/10.1097/00000441-199503000-00006
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Risk of Leukemia after Chemotherapy and Radiation Treatment for Breast CancerNew England Journal of Medicine, 1992
- Colony stimulating activity in the serum of patients with multiple myeloma is enhanced by interleukin 3: a possible role for interleukin 3 after high dose melphalan and autologous bone marrow transplantation for multiple myelomaBritish Journal of Haematology, 1990
- Autologous bone marrow transplantation with immunotoxin‐purged marrow for advanced multiple myelomaEuropean Journal of Haematology, 1989
- Marrow transplantation for malignant plasma cell disorders: Summary of the Seattle experience*European Journal of Haematology, 1989
- AUTOGRAFT USING PERIPHERAL BLOOD STEM CELLS COLLECTED AFTER HIGH DOSE MELPHALAN IN HIGH RISK MULTIPLE MYELOMABritish Journal of Haematology, 1988
- The development of high dose melphalan and of autologous bone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St Bartholomew's hospital studiesHematological Oncology, 1988
- AUTOLOGOUS STEM CELL TRANSPLANTATION USING PERIPHERAL BLOOD STEM CELLSTransplantation, 1987
- Autologous transplantation with circulating hemopoietic stem cellsJournal of Clinical Apheresis, 1987
- Peripheral blood stem cell autograftingHematological Oncology, 1987
- The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute LeukemiaNew England Journal of Medicine, 1979